Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kolesnick

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
Cell Metabolism|December 3, 2014
C16:0-ceramide signals insulin resistanceTimothy Hla, Richard Kolesnick
Leukemia|August 30, 2002
Sphingosine 1-phosphate as a therapeutic agentS Spiegel, R Kolesnick
Seminars in Radiation Oncology|October 1, 1996
Modulation of the Apoptotic Response: Potential for Improving the Outcome in Clinical RadiotherapyHaimovitz-Friedman, Kolesnick, Fuks
Cancer Cell|August 16, 2005
Engaging the vascular component of the tumor responseZvi Fuks, Richard Kolesnick
Handbook of Experimental Pharmacology|April 9, 2013
Using ASMase knockout mice to model human diseasesGuoqiang Hua, Richard Kolesnick
Biological Chemistry|February 27, 2015
Caenorhabditis elegans as a model to study sphingolipid signalingXinzhu Deng, Richard Kolesnick
Oncogene|October 15, 2003
Raft ceramide in molecular medicineErich Gulbins, Richard Kolesnick
Pharmacological Research|April 5, 2003
Sphingolipids as therapeuticsMark Kester, Richard Kolesnick
Advances in Lipid Research|January 1, 1993
Ceramide: a novel second messengerS Mathias, R Kolesnick
Oncogene|August 30, 2003
Radiation and ceramide-induced apoptosisRichard Kolesnick, Zvi Fuks
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
Cell Metabolism|December 3, 2014
C16:0-ceramide signals insulin resistanceTimothy Hla, Richard Kolesnick
Leukemia|August 30, 2002
Sphingosine 1-phosphate as a therapeutic agentS Spiegel, R Kolesnick
Seminars in Radiation Oncology|October 1, 1996
Modulation of the Apoptotic Response: Potential for Improving the Outcome in Clinical RadiotherapyHaimovitz-Friedman, Kolesnick, Fuks
Cancer Cell|August 16, 2005
Engaging the vascular component of the tumor responseZvi Fuks, Richard Kolesnick
Handbook of Experimental Pharmacology|April 9, 2013
Using ASMase knockout mice to model human diseasesGuoqiang Hua, Richard Kolesnick
Biological Chemistry|February 27, 2015
Caenorhabditis elegans as a model to study sphingolipid signalingXinzhu Deng, Richard Kolesnick
Oncogene|October 15, 2003
Raft ceramide in molecular medicineErich Gulbins, Richard Kolesnick
Pharmacological Research|April 5, 2003
Sphingolipids as therapeuticsMark Kester, Richard Kolesnick
Advances in Lipid Research|January 1, 1993
Ceramide: a novel second messengerS Mathias, R Kolesnick
Oncogene|August 30, 2003
Radiation and ceramide-induced apoptosisRichard Kolesnick, Zvi Fuks
Pageof 19